Cosentyx’s IL-17A mechanism provides a differentiated approach for HS in younger patients.

Hidradenitis suppurativa is a skin disease that causes outbreaks of bumps and abscesses. It's thought to affect around 1% of ...

The FDA has approved secukinumab (Cosentyx; Novartis) for the treatment of pediatric patients 12 years and older with moderate to severe hidradenitis suppurativa (HS), the company announced. 1 The ...

HS severely impacts QOL, with delayed diagnosis worsening disease severity and outcomes, necessitating early intervention and improved care access. Pain, emotional distress, and socioeconomic ...

Maybe it’s that new exercise program you’ve been following. Or maybe you just sweat a lot. Whatever the reason, you’ve noticed a bunch of red bumps on your skin lately, especially in the folds of your ...

Treatment for hidradenitis suppurativa (HS) varies depending on the condition’s severity. Early HS can be manageable with medication, while more severe cases may require both medication and surgery.

Jul. 17, 2025 -- What is hidradenitis suppurativa (HS)? Why is it often misdiagnosed, and what does effective care look like? We spoke to Jennifer L. Hsiao, MD, dermatologist and director of the ...

Living with a skin condition like hidradenitis suppurativa (HS) or folliculitis can be challenging, especially when you’re not sure what’s causing your symptoms. Both of these conditions cause ...

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition before—and so many people have not, even though HS is not actually rare (it ...

MoonLake Immunotherapeutics (MLTX) is gearing up to report results from its two phase 3 studies, known as VELA-1 and VELA-2. Both of these late-stage studies use the company's drug sonelokimab for the ...

Hidradenitis suppurativa (HS) is a chronic skin condition that affects the sweat glands and hair follicles. Stage 1 is the mildest form of the condition. HS, or acne inversa, commonly appears where ...